These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1151704)
1. Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats. Sofia RD; Diamantis W; Ludwig BJ J Pharm Sci; 1975 Aug; 64(8):1321-4. PubMed ID: 1151704 [TBL] [Abstract][Full Text] [Related]
2. Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395). Sofia RD; Diamantis W; Gordon R; Kletzkin M; Berger FM; Edelson J; Singer H; Douglas JF Eur J Pharmacol; 1974 Apr; 26(1):51-62. PubMed ID: 4545529 [No Abstract] [Full Text] [Related]
3. Absorption, distribution, and metabolic fate of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one in rats, dogs, and humans. Edelson J; Douglas JF; Ludwig BJ; Schuster EB; Shahinian S J Pharm Sci; 1975 Aug; 64(8):1316-21. PubMed ID: 1097636 [TBL] [Abstract][Full Text] [Related]
4. The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent. Berger FM; Bates HM; Diamantis W; Kletzkin M; Plekss OJ; Sofia RD; Spencer HJ Pharmacology; 1973; 9(3):164-76. PubMed ID: 4714232 [No Abstract] [Full Text] [Related]
5. Synthesis and anti-inflammatory activity of 3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]benzoxazin-9-ones and related compounds. Reisner DB; Ludwig BJ; Stiefel FJ; Gister S; Meyer M; Powell LS; Sofia RD Arzneimittelforschung; 1977; 27(4):760-6. PubMed ID: 301390 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity. Sofia RD; Diamantis W; Ludwig BJ Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418 [No Abstract] [Full Text] [Related]
7. The in vivo antibradykinin activity of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one), a new anti-inflammatory agent. Hrdina PD; Ling GM Pharmacology; 1973; 10(3):136-42. PubMed ID: 4761775 [No Abstract] [Full Text] [Related]
8. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones. Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391 [TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, and metabolic fate of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one). Edelson J; Douglas JF; Ludwig BJ J Pharm Sci; 1973 Feb; 62(2):229-32. PubMed ID: 4631323 [No Abstract] [Full Text] [Related]
10. NMR determination of enantiomers of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo(3,2-b)(1,3)benzoxazin-9-one using chiral shift reagent, tris(3-(heptafluorobutyryl)-d-camphorato)europium(III). Reisberg P; Brenner IA; Bodin JI J Pharm Sci; 1976 Apr; 65(4):592-4. PubMed ID: 1271263 [TBL] [Abstract][Full Text] [Related]
11. NMR assay of diastereoisomers of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo(3,2-b)(1,3) benzoxazin-9-one using deuterated tris(1,1,1,2,2,3,3-heptafluoro-7,7-dimethyl-4,6-octanedionato)europium III shift reagent. Reisberg P; Brenner IA; Bodin JI J Pharm Sci; 1974 Oct; 63(10):1586-91. PubMed ID: 4436793 [No Abstract] [Full Text] [Related]
12. Comparative gastric ulcerogenic effects of meseclazone, 5-chlorosalicylic acid and other nonsteroidal anti-inflammatory drugs following acute and repeated oral administration to rats. Diamantis W; Melton J; Sofia RD; Ciofalo VB Toxicol Appl Pharmacol; 1980 Mar; 52(3):454-61. PubMed ID: 6768168 [No Abstract] [Full Text] [Related]
13. Comparative antiphlogistic activity of meseclazone, 5-chlorosalicylic acid, acetylsalicylic acid, phenylbutazone, indomethacin and hydrocortisone in various rat paw edema models. Sofia RD Pharmacology; 1978; 16(3):148-52. PubMed ID: 628674 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and analgesic properties of etodolic acid in rats. Martel RR; Klicius J Can J Physiol Pharmacol; 1976 Jun; 54(3):245-8. PubMed ID: 953855 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation. Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977 [No Abstract] [Full Text] [Related]
16. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation. Diamantis W; Kohlhepp WC; Haertlein B; Melton J; Sofia RD Thromb Haemost; 1978 Aug; 40(1):24-36. PubMed ID: 103240 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological study of some 3-(isoxazol-5-yl)-quinazolin-4(3H)-ones. Plescia S; Daidone G; Raffa D; Bajardi ML; Caruso A; Cutuli V; Amico-Roxas M Farmaco; 1992 Apr; 47(4):465-75. PubMed ID: 1388594 [TBL] [Abstract][Full Text] [Related]